Replies to post #195174 on Biotech Values

[DewDiligence]

Re: 21st Century Cures Act /market exclusivity

Such conveyance could include the sale of exclusivity from one company to another company and would also apply to Orange Book-listed patents.

If enacted, this kind of trading in Orange-Book and H-W exclusivity will likely bring chaos to the US generic-drug market. I would submit that this process works reasonably well now, and ought to be left the way it is.